Session

Clinical aspects of upper GI malignancy

FAILURE OF MAPS II CRITERIA TO SELECT FOR SURVEILLANCE A LARGE PROPORTION OF PATIENTS PRESENTING WITH EARLY GASTRIC CANCER
FAILURE OF MAPS II CRITERIA TO SELECT FOR SURVEILLANCE A LARGE PROPORTION OF PATIENTS PRESENTING WITH EARLY GASTRIC CANCER

GERMLINE COPY NUMBER VARIANTS: AN UNDERREPORTED GENETIC DIAGNOSIS IN GASTROINTESTINAL TUMOUR RISK SYNDROME SUSPECTED INDIVIDUALS
GERMLINE COPY NUMBER VARIANTS: AN UNDERREPORTED GENETIC DIAGNOSIS IN GASTROINTESTINAL TUMOUR RISK SYNDROME SUSPECTED INDIVIDUALS

NEW GASTRIC CANCER DETECTION RATE ONE YEAR AFTER INTENSIVE ENDOSCOPIC SURVEILLANCE FOR THE STOMACH IN HIGH-RISK PATIENTS: A LARGE PROSPECTIVE COHORT STUDY IN JAPAN
NEW GASTRIC CANCER DETECTION RATE ONE YEAR AFTER INTENSIVE ENDOSCOPIC SURVEILLANCE FOR THE STOMACH IN HIGH-RISK PATIENTS: A LARGE PROSPECTIVE COHORT STUDY IN JAPAN

DYSPLASTIC CYSTIC FUNDIC GLAND POLYPS: RATE AND MORBIDITY IN NON-FAMILIAL ADENOMATOUS POLYPOSIS SYNDROME
DYSPLASTIC CYSTIC FUNDIC GLAND POLYPS: RATE AND MORBIDITY IN NON-FAMILIAL ADENOMATOUS POLYPOSIS SYNDROME

RISK FACTORS FOR GASTRIC CANCER IN PATIENTS WITH LYNCH SYNDROME
RISK FACTORS FOR GASTRIC CANCER IN PATIENTS WITH LYNCH SYNDROME

MANAGEMENT OF TYPE-I GASTRIC NEUROENDOCRINE NEOPLASMS: A SINGLE CENTER'S REAL WORLD EXPERIENCE
MANAGEMENT OF TYPE-I GASTRIC NEUROENDOCRINE NEOPLASMS: A SINGLE CENTER'S REAL WORLD EXPERIENCE

RISK FACTORS FOR GASTRIC CANCER IN PATIENTS WITH LYNCH SYNDROME
RISK FACTORS FOR GASTRIC CANCER IN PATIENTS WITH LYNCH SYNDROME

Clinical aspects of upper GI malignancy

MANAGEMENT OF TYPE-I GASTRIC NEUROENDOCRINE NEOPLASMS: A SINGLE CENTER’S REAL WORLD EXPERIENCE
MANAGEMENT OF TYPE-I GASTRIC NEUROENDOCRINE NEOPLASMS: A SINGLE CENTER’S REAL WORLD EXPERIENCE

Clinical aspects of upper GI malignancy

NEW GASTRIC CANCER DETECTION RATE ONE YEAR AFTER INTENSIVE ENDOSCOPIC SURVEILLANCE FOR THE STOMACH IN HIGH-RISK PATIENTS: A LARGE PROSPECTIVE COHORT STUDY IN JAPAN
NEW GASTRIC CANCER DETECTION RATE ONE YEAR AFTER INTENSIVE ENDOSCOPIC SURVEILLANCE FOR THE STOMACH IN HIGH-RISK PATIENTS: A LARGE PROSPECTIVE COHORT STUDY IN JAPAN

Clinical aspects of upper GI malignancy

DYSPLASTIC CYSTIC FUNDIC GLAND POLYPS: RATE AND MORBIDITY IN NON-FAMILIAL ADENOMATOUS POLYPOSIS SYNDROME
DYSPLASTIC CYSTIC FUNDIC GLAND POLYPS: RATE AND MORBIDITY IN NON-FAMILIAL ADENOMATOUS POLYPOSIS SYNDROME

Clinical aspects of upper GI malignancy

FAILURE OF MAPS II CRITERIA TO SELECT FOR SURVEILLANCE A LARGE PROPORTION OF PATIENTS PRESENTING WITH EARLY GASTRIC CANCER
FAILURE OF MAPS II CRITERIA TO SELECT FOR SURVEILLANCE A LARGE PROPORTION OF PATIENTS PRESENTING WITH EARLY GASTRIC CANCER

Clinical aspects of upper GI malignancy

GERMLINE COPY NUMBER VARIANTS: AN UNDERREPORTED GENETIC DIAGNOSIS IN GASTROINTESTINAL TUMOUR RISK SYNDROME SUSPECTED INDIVIDUALS
GERMLINE COPY NUMBER VARIANTS: AN UNDERREPORTED GENETIC DIAGNOSIS IN GASTROINTESTINAL TUMOUR RISK SYNDROME SUSPECTED INDIVIDUALS

Clinical aspects of upper GI malignancy

MANAGEMENT OF TYPE-I GASTRIC NEUROENDOCRINE NEOPLASMS: A SINGLE CENTER’S REAL WORLD EXPERIENCE
MANAGEMENT OF TYPE-I GASTRIC NEUROENDOCRINE NEOPLASMS: A SINGLE CENTER’S REAL WORLD EXPERIENCE

Clinical aspects of upper GI malignancy  et al.

RISK FACTORS FOR GASTRIC CANCER IN PATIENTS WITH LYNCH SYNDROME
RISK FACTORS FOR GASTRIC CANCER IN PATIENTS WITH LYNCH SYNDROME

Clinical aspects of upper GI malignancy  et al.

DYSPLASTIC CYSTIC FUNDIC GLAND POLYPS: RATE AND MORBIDITY IN NON-FAMILIAL ADENOMATOUS POLYPOSIS SYNDROME
DYSPLASTIC CYSTIC FUNDIC GLAND POLYPS: RATE AND MORBIDITY IN NON-FAMILIAL ADENOMATOUS POLYPOSIS SYNDROME

Clinical aspects of upper GI malignancy  et al.

NEW GASTRIC CANCER DETECTION RATE ONE YEAR AFTER INTENSIVE ENDOSCOPIC SURVEILLANCE FOR THE STOMACH IN HIGH-RISK PATIENTS: A LARGE PROSPECTIVE COHORT STUDY IN JAPAN
NEW GASTRIC CANCER DETECTION RATE ONE YEAR AFTER INTENSIVE ENDOSCOPIC SURVEILLANCE FOR THE STOMACH IN HIGH-RISK PATIENTS: A LARGE PROSPECTIVE COHORT STUDY IN JAPAN

Clinical aspects of upper GI malignancy  et al.

GERMLINE COPY NUMBER VARIANTS: AN UNDERREPORTED GENETIC DIAGNOSIS IN GASTROINTESTINAL TUMOUR RISK SYNDROME SUSPECTED INDIVIDUALS
GERMLINE COPY NUMBER VARIANTS: AN UNDERREPORTED GENETIC DIAGNOSIS IN GASTROINTESTINAL TUMOUR RISK SYNDROME SUSPECTED INDIVIDUALS

Clinical aspects of upper GI malignancy  et al.

FAILURE OF MAPS II CRITERIA TO SELECT FOR SURVEILLANCE A LARGE PROPORTION OF PATIENTS PRESENTING WITH EARLY GASTRIC CANCER
FAILURE OF MAPS II CRITERIA TO SELECT FOR SURVEILLANCE A LARGE PROPORTION OF PATIENTS PRESENTING WITH EARLY GASTRIC CANCER

Clinical aspects of upper GI malignancy  et al.

Item 1 - 18 / 18
1